Sign up to save your podcasts
Or
Share FDA considering a second Alzheimer's drug
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA considering a second Alzheimer's drug
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By POLITICO
4.7
453453 ratings
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like POLITICO's Pulse Check
View all
Economist Podcasts
4,329 Listeners
POLITICO's Off Message
610 Listeners
Playbook Deep Dive
1,525 Listeners
POLITICO Playbook Daily Briefing
635 Listeners
The Daily
111,470 Listeners
Power Play
977 Listeners
Women Rule
308 Listeners
Up First from NPR
56,179 Listeners
EU Confidential
108 Listeners
KFF Health News' 'What the Health?'
468 Listeners
POLITICO Money
207 Listeners
POLITICO Energy
131 Listeners
POLITICO Tech
391 Listeners
Westminster Insider
29 Listeners
POLITICO Berlin Playbook
5 Listeners